The Role of Corticosteroids in the Treatment of Croup
Tóm tắt
Since the 1960s, corticosteroids have been used in the treatment of laryngotracheobronchitis, commonly called croup. Initially, their use for croup was controversial and highly debated in the literature. The evidence over the last 2 decades has strongly favored corticosteroid use in croup management. It has now become the standard of care to use corticosteroids in moderate-to-severe croup. Corticosteroid use in these patients has been shown to reduce hospitalizations, length of illness, and subsequent treatments when compared with placebo. By extrapolation, corticosteroids may even play a role in patients with milder croup presenting for medical assessment. The current recommendation is to treat patients with moderate-to-severe croup with oral dexamethasone in a dose of 0.6 mg/kg (maximum 10–12mg) because of its ease of administration, easy availability, and low cost. Intramuscular dexamethasone is reserved for patients who are vomiting or who are in severe respiratory distress and unable to tolerate oral medication. Nebulized budesonide, used commonly in some geographic locations, has been found to be effective, but is often not used in favor of the oral corticosteroids. Controversy still exists over the use of corticosteroids in mild and potentially self-limiting disease. Some evidence exists for treating these patients; some clinicians use corticosteroids for all patients with croup who seek care regardless of the severity of the illness. Patients with mild disease may be candidates for lower doses of dexamethasone such as 0.15–0.3 mg/kg. Corticosteroid-induced complications in croup are rare. Overall, corticosteroids have gained universal acceptance for the treatment of croup and have been found to be effective, well tolerated, and inexpensive.
Tài liệu tham khảo
Denny FW, Murphy TF, Clyde WA, et al. Croup: an 11-year study in a pediatric practice. Pediatrics 1983 Jun; 71: 871–6
Skolnik NS. Treatment of croup. Am J Dis Child 1989 Sep; 143: 1045–9
Kaditis AG, Wald ER. Viral croup: current diagnosis and treatment. Contemp Pediatr 1999 Feb; 16: 139–53
Couriel JM. Management of croup. Arch Dis Child 1988; 63: 1305–8
Koren G, Frand M, Barzilay Z, et al. Corticocorticosteroid treatment of laryngotracheitis versus spasmodic croup in children. Am J Dis Child 1983 Oct; 137: 941–4
Zach M, Erben A, Olinsky A. Croup, recurrent croup, allergy, and airways hyperreactivity. Arch Dis Child 1981; 56: 336–41
Bjornson C, Johnson D. That characteristic cough: when to treat croup and what to use. Contemp Pediatr 2001 Oct; 18: 74–82
Klassen T. Croup: a current perspective. Pediatr Clin North Am 1999 Dec; 46: 1167–78
Stannard W, O’Callaghan C. Management of croup. Pediatr Drugs 2002; 4: 231–40
Bourchier D, Dawson K, Fergusson D. Humidification in viral croup: a controlled trial. Aust Paediatr J 1984 Nov; 20: 289–91
Neto G, Kentab O, Klassen T, et al. A randomized controlled trial of mist in the acute treatment of moderate croup. Acad Emerg Med 2002 Sep; 9: 873–9
Sammons J. Drug evaluations. 6th ed. Chicago (IL): American Medical Association Department of Drugs, 1986: 1098–9
Ausejo M, Saenz A, Pham B, et al. The effectiveness of glucocorticoids in treating croup: meta-analysis. BMJ 1999 Sep; 319: 595–600
Kuusela A, Vesikari T. A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatr Scand 1988; 77: 99–104
Klassen T, Feldman ME, Watters LK, et al. Nebulized budesonide for children with mild-to-moderate croup. N Engl J Med 1994 Aug; 331: 285–9
Husby S, Agertofe L, Mortensen S, et al. Treatment of croup with nebulised corticosteroid (budesonide): a double-blind, placebo controlled study. Arch Dis Child 1993; 68: 352–5
Geelhoed GC, Macdonald WB. Oral and inhaled corticosteroids in croup: a randomized placebo-controlled trial. Pediatr Pulmonol 1995; 20: 355–61
Melby J. Systemic corticosteroids therapy: pharmacology and endocrinologic considerations. Ann Intern Med 1974 Oct; 81: 505–12
Super DM, Cartelli NA, Brooks LJ, et al. A prospective randomized double-blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. J Pediatr 1989 Aug; 115: 323–9
Kairys SW, Olmstead EM, O’Connor GT. Corticosteroid treatment of laryngotracheitis: a meta-analysis of the evidence from randomized trials. Pediatrics 1989 May; 83: 683–93
Geelhoed GC, Macdonald WB. Oral dexamethasone in the treatment of croup: 0.15 mg/kg verus 0.3 mg/kg versus 0.6 mg/kg. Pediatr Pulmonol 1995; 20: 362–8
Fitzgerald D, Mellis C, Johnson M, et al. Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics 1996 May; 97: 722–5
Klassen TP, Craig WR, Moher D, et al. Nebulized bedesonide and oral dexamethasone for treatment of croup. JAMA 1998 May; 279: 1629–32
Godden CW, Campbell MJ, Hussey M, et al. Double blind controlled trial of nebulized budesonide for croup. Arch Dis Child 1997; 76: 155–8
Kristjansson S, Berg-Kelly K, Winso E. Inhalation of racemic adrenaline in the treatment of mild and moderately severe croup: clinical symptom score and oxygen saturation measurements for evaluation of treatment effects. Acta Paediatr 1994; 83: 1156–60
Adair JC, Ring WH, Jordan WS, et al. Ten-year experience with IPPB in the treatment of acute laryngotracheobronchitis. Anesth Analg 1971; 50: 649–55
Prendergast M, Jones JS, Hartman D. Racemic epinephrine in the treatment of laryngotracheitis: can we identify children for outpatient therapy? Am J Emerg Med 1994; 12: 613–6
Ledwith CA, Shea LM, Mauro RD. Safety and efficacy of nebulized racemic epinephrine in conjunction with oral dexamethasone and mist in the outpatient treatment of croup. Ann Emerg Med 1995; 25: 331–7
Waisman Y, Mein BL, Boenning DA, et al. Prospective randomized double-blind study comparing L-epinephrine and racemic epinephrine aerosols in the treatment of laryngotracheitis (croup). Pediatrics 1992; 89: 302–6
Hinton W, Goss J. Croup, nebulized adrenaline and preservatives. Anaesthesia 1987; 42: 436–7
Corneli HM, Bolte RG. Outpatient use of racemic epinephrine in croup. Am Fam Physician 1992; 46: 683–4
Kunkel NC, Baker MD. Use of racemic epinephrine, dexamethasone, and mist in the outpatient management of croup. Pediatr Emerg Care 1996; 12: 156–9
McDonogh AJ. The use of corticosteroids and nebulized adrenaline in the treatment of viral croup over a seven year period at a district hospital. Anaesth Intensive Care 1994; 22: 175–8
Martenson G, Nilson G, Torbjar J. The effect of corticosteroids in the treatment of pseudo-croup. Acta Otolaryngology 1960; 58Suppl. 1: 52–71
James J. Dexamethasone in croup. Am J Dis Child 1969 May; 117: 511–6
Muhlendahl KE, Kahn D, Spohr HL, et al. Corticosteroid treatment in psuedocroup. Helv Paediatr Acta 1982; 37: 431–6
Sussman S, Grossman M, Magottin R, et al. Dexamethasone (16 alpha-methyl, 9 alpha-fluoroprednisolone) in obstructive respiratory tract infections in children. Pediatrics 1964 Dec; 34: 851–5
Cherry JD. The treatment of croup: continued controversy due to failure of recognition of historic, ecologic and clinical perspectives. J Pediatr 1979 Feb; 94: 352–4
Novik A. Corticosteroid treatment of non-diphtheritic croup. Acta Otolaryngol 1960; 158Suppl. 1: 20–3
Tibballs J, Shann FA, Landau LI. Placebo-controlled trial of prednisolone in children intubated for croup. Lancet 1992 Sep; 340: 745–8
Gould J, Kost S, Plamer K, et al. Corticosteroid use by pediatric emergency medicine physicians in children with croup [abstract]. Proceedings of the Annual Meeting of the American Academy of Pediatrics, Section of Emergency Medicine; 1994 Oct 22–26; Dallas (TX). Pediatr Emerg Care 1994; 10: 315
Connors K, Gavula D, Terndrup T. The use of corticosteroids in croup: a survey. Pediatr Emerg Care 1994 Aug; 10: 197–9
Geelhoed GC. Sixteen years of croup in a Western Australian teaching hospital: effects of routine corticosteroid treatment. Ann Emerg Med 1996 Dec; 28: 621–6
Leipzig B, Oski FA, Cummings CW, et al. A prospective randomized study to determine the efficacy of corticosteroids in the treatment of croup. J Pediatr 1979 Feb; 94: 194–6
Postma DS, Jones RO, Pillsbury HC. Severe hospitalized croup: treatment trends and prognosis. Laryngoscope 1984 Sep; 94: 1170–5
Cruz MN, Stewart G, Rosenberg N. Use of dexamethasone in the outpatient management of acute laryngotracheitis. Pediatrics 1995 Aug; 96: 220–3
Schimmer BP, Panku KC. Adrenocorticotropic hormone: adrenocorticol steroids and their synthetic analogs: inhibitors of the synthesis and actions of adrenocorticol hormones. In: Hardman JG, Limbird LE, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 10th ed. New York: McGraw Hill, 2001: 1657
Geelhoed GC, Turner J, Macdonald WB. Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial. BMJ 1996; 313: 140–2
Rittichier KK, Ledwith CL. Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics 2000 Dec; 106: 1344–8
Donaldson D, Poleski D, Knipple E, et al. Intramuscular versus oral dexamethasone for the treatment of moderate-to-severe croup: a randomized, double-blind trial. Acad Emerg Med 2003 Jan; 10: 16–21
Klassen T, Watters LK, Feldman ME, et al. The efficacy of nebulized budesonide in dexamethasone-treated outpatients with croup. Pediatrics 1996 Apr; 97: 463–6
Johnson D, Schuh S, Koren G, et al. Outpatient treatment of croup with nebulized dexamethasone. Arch Pediatr Adolesc Med 1996 Apr; 150: 349–55
Johnson DW, Jacobson S, Edney PC, et al. A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. N Engl J Med 1998 Aug; 339: 498–503
Madhok M, Kost SI, Laffey SP, et al. Nebulized versus oral dexamethasone for the treatment of mild to moderate croup [abstract; poster]. Abstract and poster presentation at Pediatric Academic Societies’ Annual Meeting of the Society for Pediatric Research; 1999 May 1–4; San Francisco
Luria JW, Ganzalez-del-Rey JA, DiGiulio GA, et al. Effectiveness of oral or nebulized dexamthasone for children with mild croup. Arch Pediatr Adolesc Med 2001 Dec; 155: 1340–5
Burton DM, Seld AB, Keams DB, et al. Candida laryngotracheitis: a complication of combined corticosteroid and antibiotic usage in croup. Int J Pediatr Otorhino-laryngol 1992; 23: 171–5
Pickering L, Peter G, Baker CJ, et al., editors. Varicella-zoster infections. Red Book. Report of the Committee of Infectious Diseases. 24th ed. Elk Grove Village (IL): American Academy of Pediatrics, 2000: 624–38
Pickering L, Peter G, Baker CJ, et al., editors. Parainfluenza viral infections. Red Book. Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village (IL): American Academy of Pediatrics, 2000: 419–20
King S. Canadian Paediatric Society statement: steroid therapy for croup in children admitted to hospital. CMAJ 1992; 147(4): 429
Jothimurugan S, Hassan Z, Silverman M. Children with croup should receive cortiocorticosteroids in primary care: results of an audit [letter]. BMJ 1999 Dec; 319: 1577
Tillett A, Gould J. General practitioners must be ready to treat children [letter]. BMJ 1999 Dec; 319: 1577